Skip to main content
eilite
Learning CenterMedicare Leads

A Guide to Buying Quality Medicare Medigap Leads for Sale

October 31, 20267 min read

Medigap leads carry distinctive characteristics compared to Medicare Advantage leads, given Medigap's different enrollment rules and typically higher-income, health-conscious buyer profile, making a somewhat specialized evaluation approach worthwhile when buying this specific lead type rather than applying the same criteria used for Medicare Advantage volume.

What Distinguishes Medigap Leads

Medigap prospects often research more extensively before purchasing, given the product's different cost structure and underwriting considerations, meaning quality Medigap leads should reflect this more informed, deliberate buyer profile rather than a casual inquiry generated from a broad, low-intent ad.

What Realistic Pricing Looks Like

Medigap leads generally cost more than standard Medicare Advantage leads because the audience is smaller, more affluent, and requires more deliberate targeting to reach. Agents should expect Medigap-specific pricing to sit above generic Medicare Advantage lead pricing, and should treat a Medigap lead priced suspiciously close to an Advantage lead as a signal the provider may not be sourcing it with genuine Medigap-specific targeting.

Evaluating a Provider's Medigap-Specific Experience

Asking a prospective provider specifically about their experience generating Medigap leads, as distinct from Medicare Advantage, reveals whether they genuinely understand this product's unique dynamics or are applying a generic Medicare approach without this specific focus.

A Buying Checklist for Medigap Leads

  • Confirm genuine, verifiable Medigap-specific sourcing experience.
  • Ask about screening for underwriting-relevant health questions.
  • Compare exclusivity options and their associated pricing.
  • Request references from agents specializing in Medigap sales.
  • Ask how recently the contact data was collected.

Spotting Recycled or Stale Medigap Contacts

Recycled leads, contacts resold after failing to convert for a previous buyer, are a common quality problem in this space. Warning signs include a provider unwilling to disclose how recently data was collected, prospects who report having already spoken with multiple agents about the same inquiry, or pricing that seems too low relative to the specialized nature of genuine Medigap targeting.

Understanding Underwriting Considerations in Screening

Quality Medigap lead screening should account for basic health question responses relevant to underwriting, since a lead who may face underwriting complications represents different sales dynamics than one likely to qualify smoothly, particularly outside a guaranteed-issue window.

Comparing Exclusive and Shared Medigap Options

As with other Medicare lead types, exclusive Medigap leads typically cost more but convert better, and agents should weigh this tradeoff based on their own intake capacity and typical Medigap sales conversion experience.

Testing a New Medigap Provider Carefully

Starting with a smaller trial purchase before committing to larger ongoing volume lets agents confirm a new Medigap-specific provider's actual lead quality matches their marketing claims before significant budget is at stake.

Measuring Medigap Lead Performance Specifically

Tracking cost per enrolled Medigap client, separate from Medicare Advantage metrics, gives agents a clearer picture of whether their specific Medigap sourcing strategy, potentially including a specialized provider found through Eilite's buy leads platform, is producing worthwhile results.

Building Genuine Expertise in Medigap Underwriting

Agents who build genuine, ongoing familiarity with underwriting nuances across different Medigap carriers can more accurately assess a lead's realistic likelihood of qualifying, helping them prioritize follow-up efforts more effectively than agents without this specialized knowledge. This underwriting familiarity also helps agents set appropriate expectations with prospects early, reducing the frustration that can arise if a plan change turns out to be more complicated than initially anticipated.

How Guaranteed-Issue Timing Affects Lead Value

A Medigap lead reaching out during a guaranteed-issue window, such as shortly after losing other coverage, generally represents significantly higher value than one outside such a window, since medical underwriting can complicate or delay enrollment considerably. Providers who can flag or prioritize these time-sensitive leads offer a meaningful advantage.

Working With Multiple Medigap Carriers

Since Medigap plans are standardized by letter but priced differently across carriers, agents who can compare offerings across several carriers are better positioned to convert a price-sensitive Medigap lead than one representing a single carrier, making carrier diversity a meaningful part of an effective Medigap sales approach.

Setting Realistic Expectations on Sales Cycle Length

Medigap prospects often take longer to reach a decision than Medicare Advantage prospects, given the higher premium commitment and more deliberate research many undertake before enrolling, so agents should plan a somewhat longer, more patient follow-up cadence for Medigap leads rather than expecting the faster close common in Medicare Advantage sales.

Reviewing Medigap Lead Sources Each Enrollment Season

Given how much guaranteed-issue rules and carrier pricing can shift year to year, revisiting which Medigap lead sources are delivering genuine value each season, rather than assuming last year's best source remains the best choice, helps agents stay aligned with a market that changes more than it might initially appear.

FAQ

Frequently Asked Questions

Medigap prospects represent a smaller, more affluent, and more deliberate audience that requires more specialized targeting to reach, and that narrower, more informed pool generally commands a higher price than broader Medicare Advantage lead volume.

Ready to grow your Medicare book of business?

Talk to our team about live, validated Medicare leads.